Clinical Trial Update: Vicriviroc in HIV-Treatment Experienced Subjects (Study P04889AM8)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial update for vicriviroc in treatment-experienced HIV patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infections

Drugs mentioned

• Vicriviroc (MK-7690)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: HIV Infections, Acquired Immunodeficiency Syndrome | Phase 3 | Status: COMPLETED